Clinical Trials on Cardiovascular High-Risk

Total 10000 results

Alnylam Pharmaceuticals
Hoffmann-La Roche

Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease (ZENITH)

Hypertension | High Cardiovascular Risk | High Risk Cardiovascular Disease

United States, Belgium, Germany, Hungary, Italy, Poland, Portugal, Spain, United Kingdom, Taiwan, Bulgaria, Argentina, Serbia, Austria, Czechia, Turkey (Türkiye), Canada, Brazil, France, Japan, Greece, Netherlands, New Zealand, Australia and more
Centre Hospitalier Universitaire Dijon

Terminated

Retinal Microvascularization and Cardiovascular Disease (NESTOR)

High Cardiovascular Risk Patients | Low Cardiovascular Risk Patients

France
Centre Hospitalier Universitaire de Saint Etienne

Terminated

Stress Test on the Prediction of Cardiovascular Events in a High-risk Firefighter Population (FIRE-PREV)

Firefighter | High Cardiovascular Risk

France
Institute for Clinical Effectiveness and Health...
Inter-American Development Bank

Unknown

Effectiveness of Financial Incentives and Text Messages to Improve Health Care in Population With Moderate and High Cardiovascular Risk

Moderate and High Cardiovascular Risk

Argentina
Memorial Sloan Kettering Cancer Center

Completed

Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events

High Risk for Postoperative Cardiovascular Events

United States

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe